人間狂犬病免疫グロブリン（IM）のグローバル市場2021

• 英文タイトル：Global Human Rabies Immunoglobulin (IM) Sales Market Report 2021

• レポートコード：QAF27723
• 出版社/出版日：QYResearch / 2021年4月5日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、145ページ
• 納品方法：Eメール（即日納品）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界の人間狂犬病免疫グロブリン（IM）市場について種類別（ERIG、HRIG）、用途別（カテゴリーII暴露、カテゴリーIII暴露）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・人間狂犬病免疫グロブリン（IM）市場の概要
・世界の主要地域別人間狂犬病免疫グロブリン（IM）市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の人間狂犬病免疫グロブリン（IM）市場規模2016-2021：種類別（ERIG、HRIG）
・世界の人間狂犬病免疫グロブリン（IM）市場予測2012-2027：種類別（ERIG、HRIG）
・世界の人間狂犬病免疫グロブリン（IM）市場規模2016-2021：用途別（カテゴリーII暴露、カテゴリーIII暴露）
・世界の人間狂犬病免疫グロブリン（IM）市場予測2012-2027：用途別（カテゴリーII暴露、カテゴリーIII暴露）
・人間狂犬病免疫グロブリン（IM）のアメリカ市場規模と予測2016-2021
・人間狂犬病免疫グロブリン（IM）のヨーロッパ市場規模と予測2016-2021
・人間狂犬病免疫グロブリン（IM）の中国市場規模と予測2016-2021
・人間狂犬病免疫グロブリン（IM）の日本市場規模と予測2016-2021
・人間狂犬病免疫グロブリン（IM）の東南アジア市場規模と予測2016-2021
・人間狂犬病免疫グロブリン（IM）のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（CSL Behring、Grifols、Sanofi、Sichuan Yuanda Shuyang、CNBG、Kamada、CBPO、Shuanglin Bio、Weiguang Bio、Shanghai RAAS、Bharat Serum、VINS）
・人間狂犬病免疫グロブリン（IM）の製造コスト分析
・販売チャネル、流通業者、顧客
・人間狂犬病免疫グロブリン（IM）の市場動向・機会・課題
・調査の結論

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient’s passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. It is given after the wound is cleaned with soap and water or providone-iodine and is followed by a course of rabies vaccine.

Market Analysis and Insights: Global Human Rabies Immunoglobulin (IM) Market
The global Human Rabies Immunoglobulin (IM) market was valued at US$ 367.8 in 2020 and will reach US$ 527.7 million by the end of 2027, growing at a CAGR of 6.2% during 2022-2027.

Global Human Rabies Immunoglobulin (IM) Scope and Market Size
The global Human Rabies Immunoglobulin (IM) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Rabies Immunoglobulin (IM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
ERIG
HRIG

Segment by Application
Category II Exposure
Category III Exposure

The Human Rabies Immunoglobulin (IM) market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Rabies Immunoglobulin (IM) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS

レポート目次

1 Human Rabies Immunoglobulin (IM) Market Overview
1.1 Human Rabies Immunoglobulin (IM) Product Scope
1.2 Human Rabies Immunoglobulin (IM) Segment by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2016 & 2021 & 2027)
1.2.2 ERIG
1.2.3 HRIG
1.3 Human Rabies Immunoglobulin (IM) Segment by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Rabies Immunoglobulin (IM) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Rabies Immunoglobulin (IM) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Rabies Immunoglobulin (IM) Price Trends (2016-2027)

2 Human Rabies Immunoglobulin (IM) Estimates and Forecasts by Region
2.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Rabies Immunoglobulin (IM) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2016-2021)
2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2016-2021)
2.3 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Rabies Immunoglobulin (IM) Estimates and Projections (2016-2027)
2.4.2 Europe Human Rabies Immunoglobulin (IM) Estimates and Projections (2016-2027)
2.4.3 China Human Rabies Immunoglobulin (IM) Estimates and Projections (2016-2027)
2.4.4 Japan Human Rabies Immunoglobulin (IM) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Rabies Immunoglobulin (IM) Estimates and Projections (2016-2027)
2.4.6 India Human Rabies Immunoglobulin (IM) Estimates and Projections (2016-2027)
3 Global Human Rabies Immunoglobulin (IM) Competition Landscape by Players
3.1 Global Top Human Rabies Immunoglobulin (IM) Players by Sales (2016-2021)
3.2 Global Top Human Rabies Immunoglobulin (IM) Players by Revenue (2016-2021)
3.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2020)
3.4 Global Human Rabies Immunoglobulin (IM) Average Price by Company (2016-2021)
3.5 Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Rabies Immunoglobulin (IM) Market Size by Type
4.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Type (2016-2021)
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
4.1.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2016-2021)
4.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2022-2027)
4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Type (2022-2027)
5 Global Human Rabies Immunoglobulin (IM) Market Size by Application
5.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Application (2016-2021)
5.1.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
5.1.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2016-2021)
5.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2022-2027)
5.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Application (2022-2027)

6 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures
6.1 North America Human Rabies Immunoglobulin (IM) Sales by Company
6.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Company (2016-2021)
6.1.2 North America Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021)
6.2 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Type
6.2.1 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2022-2027)
6.3 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Application
6.3.1 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2022-2027)

7 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures
7.1 Europe Human Rabies Immunoglobulin (IM) Sales by Company
7.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Company (2016-2021)
7.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021)
7.2 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Type
7.2.1 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2022-2027)
7.3 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Human Rabies Immunoglobulin (IM) Market Facts & Figures
8.1 China Human Rabies Immunoglobulin (IM) Sales by Company
8.1.1 China Human Rabies Immunoglobulin (IM) Sales by Company (2016-2021)
8.1.2 China Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021)
8.2 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Type
8.2.1 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2016-2021)
8.2.2 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2022-2027)
8.3 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Human Rabies Immunoglobulin (IM) Market Facts & Figures
9.1 Japan Human Rabies Immunoglobulin (IM) Sales by Company
9.1.1 Japan Human Rabies Immunoglobulin (IM) Sales by Company (2016-2021)
9.1.2 Japan Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021)
9.2 Japan Human Rabies Immunoglobulin (IM) Sales Breakdown by Type
9.2.1 Japan Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2022-2027)
9.3 Japan Human Rabies Immunoglobulin (IM) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Rabies Immunoglobulin (IM) Market Facts & Figures
10.1 Southeast Asia Human Rabies Immunoglobulin (IM) Sales by Company
10.1.1 Southeast Asia Human Rabies Immunoglobulin (IM) Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021)
10.2 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Breakdown by Type
10.2.1 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Human Rabies Immunoglobulin (IM) Market Facts & Figures
11.1 India Human Rabies Immunoglobulin (IM) Sales by Company
11.1.1 India Human Rabies Immunoglobulin (IM) Sales by Company (2016-2021)
11.1.2 India Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021)
11.2 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Type
11.2.1 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2016-2021)
11.2.2 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2022-2027)
11.3 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Application
11.3.1 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2016-2021)
11.3.2 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Rabies Immunoglobulin (IM) Business
12.1 CSL Behring
12.1.1 CSL Behring Corporation Information
12.1.2 CSL Behring Business Overview
12.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Products Offered
12.1.5 CSL Behring Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Human Rabies Immunoglobulin (IM) Products Offered
12.2.5 Grifols Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Human Rabies Immunoglobulin (IM) Products Offered
12.3.5 Sanofi Recent Development
12.4 Sichuan Yuanda Shuyang
12.4.1 Sichuan Yuanda Shuyang Corporation Information
12.4.2 Sichuan Yuanda Shuyang Business Overview
12.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Products Offered
12.4.5 Sichuan Yuanda Shuyang Recent Development
12.5 CNBG
12.5.1 CNBG Corporation Information
12.5.2 CNBG Business Overview
12.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CNBG Human Rabies Immunoglobulin (IM) Products Offered
12.5.5 CNBG Recent Development
12.6 Kamada
12.6.1 Kamada Corporation Information
12.6.2 Kamada Business Overview
12.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Kamada Human Rabies Immunoglobulin (IM) Products Offered
12.6.5 Kamada Recent Development
12.7 CBPO
12.7.1 CBPO Corporation Information
12.7.2 CBPO Business Overview
12.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 CBPO Human Rabies Immunoglobulin (IM) Products Offered
12.7.5 CBPO Recent Development
12.8 Shuanglin Bio
12.8.1 Shuanglin Bio Corporation Information
12.8.2 Shuanglin Bio Business Overview
12.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Products Offered
12.8.5 Shuanglin Bio Recent Development
12.9 Weiguang Bio
12.9.1 Weiguang Bio Corporation Information
12.9.2 Weiguang Bio Business Overview
12.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Products Offered
12.9.5 Weiguang Bio Recent Development
12.10 Shanghai RAAS
12.10.1 Shanghai RAAS Corporation Information
12.10.2 Shanghai RAAS Business Overview
12.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Products Offered
12.10.5 Shanghai RAAS Recent Development
12.11 Bharat Serum
12.11.1 Bharat Serum Corporation Information
12.11.2 Bharat Serum Business Overview
12.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Products Offered
12.11.5 Bharat Serum Recent Development
12.12 VINS
12.12.1 VINS Corporation Information
12.12.2 VINS Business Overview
12.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 VINS Human Rabies Immunoglobulin (IM) Products Offered
12.12.5 VINS Recent Development

13 Human Rabies Immunoglobulin (IM) Manufacturing Cost Analysis
13.1 Human Rabies Immunoglobulin (IM) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
13.4 Human Rabies Immunoglobulin (IM) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Rabies Immunoglobulin (IM) Distributors List
14.3 Human Rabies Immunoglobulin (IM) Customers

15 Market Dynamics
15.1 Human Rabies Immunoglobulin (IM) Market Trends
15.2 Human Rabies Immunoglobulin (IM) Drivers
15.3 Human Rabies Immunoglobulin (IM) Market Challenges
15.4 Human Rabies Immunoglobulin (IM) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Rabies Immunoglobulin (IM) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Rabies Immunoglobulin (IM) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Region (2016-2021)
Table 5. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2016-2021)
Table 6. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue Share by Region (2016-2021)
Table 8. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Rabies Immunoglobulin (IM) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Rabies Immunoglobulin (IM) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Human Rabies Immunoglobulin (IM) Sales Share by Company (2016-2021)
Table 14. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Rabies Immunoglobulin (IM) Revenue Share by Company (2016-2021)
Table 16. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2020)
Table 17. Global Human Rabies Immunoglobulin (IM) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Sites and Area Served
Table 19. Manufacturers Human Rabies Immunoglobulin (IM) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2016-2021)
Table 22. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2016-2021)
Table 23. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2022-2027)
Table 26. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2022-2027)
Table 28. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2016-2021)
Table 30. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2016-2021)
Table 31. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2022-2027)
Table 34. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2022-2027)
Table 35. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2022-2027)
Table 37. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2016-2021)
Table 39. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2021)
Table 40. North America Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2016-2021)
Table 42. North America Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 43. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
Table 44. North America Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 45. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2022-2027)
Table 46. North America Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 47. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
Table 48. North America Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 49. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2022-2027)
Table 50. Europe Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2016-2021)
Table 51. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2021)
Table 52. Europe Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 55. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
Table 56. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 57. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2022-2027)
Table 58. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
Table 60. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2022-2027)
Table 62. China Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2016-2021)
Table 63. China Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2021)
Table 64. China Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2016-2021)
Table 66. China Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 67. China Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
Table 68. China Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 69. China Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2022-2027)
Table 70. China Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 71. China Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
Table 72. China Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 73. China Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2022-2027)
Table 74. Japan Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2016-2021)
Table 75. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2021)
Table 76. Japan Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 79. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
Table 80. Japan Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 81. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2022-2027)
Table 82. Japan Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
Table 84. Japan Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2022-2027)
Table 98. India Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2016-2021)
Table 99. India Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2021)
Table 100. India Human Rabies Immunoglobulin (IM) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2016-2021)
Table 102. India Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 103. India Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
Table 104. India Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 105. India Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2022-2027)
Table 106. India Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 107. India Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
Table 108. India Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 109. India Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2022-2027)
Table 110. CSL Behring Corporation Information
Table 111. CSL Behring Description and Business Overview
Table 112. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 114. CSL Behring Recent Development
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Business Overview
Table 117. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Grifols Human Rabies Immunoglobulin (IM) Product
Table 119. Grifols Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 124. Sanofi Recent Development
Table 125. Sichuan Yuanda Shuyang Corporation Information
Table 126. Sichuan Yuanda Shuyang Description and Business Overview
Table 127. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 129. Sichuan Yuanda Shuyang Recent Development
Table 130. CNBG Corporation Information
Table 131. CNBG Description and Business Overview
Table 132. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. CNBG Human Rabies Immunoglobulin (IM) Product
Table 134. CNBG Recent Development
Table 135. Kamada Corporation Information
Table 136. Kamada Description and Business Overview
Table 137. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Kamada Human Rabies Immunoglobulin (IM) Product
Table 139. Kamada Recent Development
Table 140. CBPO Corporation Information
Table 141. CBPO Description and Business Overview
Table 142. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. CBPO Human Rabies Immunoglobulin (IM) Product
Table 144. CBPO Recent Development
Table 145. Shuanglin Bio Corporation Information
Table 146. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Shuanglin Bio Description and Business Overview
Table 148. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 149. Shuanglin Bio Recent Development
Table 150. Weiguang Bio Corporation Information
Table 151. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Weiguang Bio Description and Business Overview
Table 153. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 154. Weiguang Bio Recent Development
Table 155. Shanghai RAAS Corporation Information
Table 156. Shanghai RAAS Description and Business Overview
Table 157. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 159. Shanghai RAAS Recent Development
Table 160. Bharat Serum Corporation Information
Table 161. Bharat Serum Description and Business Overview
Table 162. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 164. Bharat Serum Recent Development
Table 165. VINS Corporation Information
Table 166. VINS Description and Business Overview
Table 167. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. VINS Human Rabies Immunoglobulin (IM) Product
Table 169. VINS Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Human Rabies Immunoglobulin (IM) Distributors List
Table 173. Human Rabies Immunoglobulin (IM) Customers List
Table 174. Human Rabies Immunoglobulin (IM) Market Trends
Table 175. Human Rabies Immunoglobulin (IM) Market Drivers
Table 176. Human Rabies Immunoglobulin (IM) Market Challenges
Table 177. Human Rabies Immunoglobulin (IM) Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Product Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2021 & 2027
Figure 6. Category II Exposure Examples
Figure 7. Category III Exposure Examples
Figure 8. Global Human Rabies Immunoglobulin (IM) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Human Rabies Immunoglobulin (IM) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Human Rabies Immunoglobulin (IM) Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue in Human Rabies Immunoglobulin (IM): 2016 & 2020
Figure 27. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2016-2021)
Figure 29. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2016-2021)
Figure 31. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2020
Figure 33. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2020
Figure 34. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2020
Figure 35. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2020
Figure 36. China Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2020
Figure 37. China Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2020
Figure 38. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2020
Figure 39. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2020
Figure 40. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2020
Figure 41. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2020
Figure 42. India Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2020
Figure 43. India Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Human Rabies Immunoglobulin (IM)
Figure 46. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 47. Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

以下、関連資料のご紹介

世界のヒト狂犬病治療市場規模・現状・予測（2021年-2027年）

Global Human Rabies Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5788 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ヒト狂犬病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細胞培養ワクチン、狂犬病免疫グロブリン、神経組織ワクチン）、用途別市場規模（暴露前免疫、暴露後予防）、主要地域別市場規模（北米、アメリカ、...

静注用免疫グロブリン（IVIg）のグローバル市場2021

Global Intravenous Immunoglobulin (IVIg) Sales Market Report 2021
QAF27747 2021年3月31日 144Pages
本市場調査資料では、世界の静注用免疫グロブリン（IVIg）市場について種類別（IVIg液、IVIg粉）、用途別（免疫不全症、自己免疫疾患、急性感染症）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上...

世界の狂犬病治療市場規模・現状・予測（2021年-2027年）

Global Rabies Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4788 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、狂犬病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細胞培養ワクチン（CCV）、狂犬病免疫グロブリン（RIG）、神経組織ワクチン（NTV））、用途別市場規模（暴露前予防、暴露後予防）、主要地域別...

ヒト狂犬病ワクチンのグローバル市場調査 2019年

Global Human Rabies Vaccine Market Professional Survey Report 2019
QYR9NV06359 2019年11月12日 103Pages
※本調査レポートは、ヒト狂犬病ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他に、...

ヒト破傷風免疫グロブリンのグローバル市場調査 2019年

Global Human Tetanus Immunoglobulin Market Professional Survey Report 2019
QYR9NV06362 2019年11月12日 102Pages
※本調査レポートは、ヒト破傷風免疫グロブリンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、注入、凍結乾燥注入に、用途別には、大人、子供にセグメント区分し、ヒ...

狂犬病ワクチンのグローバル市場2021

Global Rabies Vaccine Sales Market Report 2021
QAF27867 2021年4月1日 137Pages
本市場調査資料では、世界の狂犬病ワクチン市場について種類別（ベロ細胞狂犬病ワクチン、BHK、ひよこ胚細胞狂犬病ワクチン、その他）、用途別（暴露前予防、暴露後予防）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（...

ヒトB型肝炎免疫グロブリン（HBIG）のグローバル市場調査 2019年

Global Human Hepatitis B Immunoglobulin (HBIG) Market Professional Survey Report 2019
QYR9NV06351 2019年11月12日 115Pages
※本調査レポートは、ヒトB型肝炎免疫グロブリン（HBIG）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、100IU /ボトルヒトB型肝炎免疫グロブリン、20...

母乳オリゴ糖（HMO）のグローバル市場2021

Global Human Milk Oligosaccharides (HMO) Sales Market Report 2021
QAF24767 2021年4月7日 139Pages
本市場調査資料では、世界の母乳オリゴ糖（HMO）市場について種類別（2'-FL＆3-FL、シアリルラクトース、LNT＆LNnT）、用途別（粉ミルク、機能性食品＆飲料、食品/医薬品サプリメント、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。201...

世界の低親和性免疫グロブリンガンマFc領域受容体II-B市場規模・現状・予測（2021年-2027年）

Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size, Status and Forecast 2021-2027
QFJ1-5834 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、低親和性免疫グロブリンガンマFc領域受容体II-Bの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（XmAb-7195、BI-1206、MGD-010、SM-201、その他）、用途別市場規模（病院、クリ...

世界の狂犬病モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global Rabies Monoclonal Antibody Market Size, Status and Forecast 2021-2027
QFJ1-5502 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、狂犬病モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カテゴリーII暴露、カテゴリーIII暴露）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のヒト狂犬病治療市場規模・現状・予測（2021年-2027年） Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem. Market Analysis and Insights: Global Human Rabies Treatment Market The global Human Rabies Treatment market size is projected to reach US$ XX million by 2027, f…
ヒト狂犬病ワクチンのグローバル市場調査 2019年 The global Human Rabies Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Rabies Vaccine volume and value at global level, regional level and company level. From a global perspective, th…
ヒト破傷風免疫グロブリンのグローバル市場調査 2019年 The global Human Tetanus Immunoglobulin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Tetanus Immunoglobulin volume and value at global level, regional level and company level. From a global…
世界の狂犬病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rabies Treatment Market The global Rabies Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
世界の狂犬病モノクローナル抗体市場規模・現状・予測（2021年-2027年） Anti-rabies virus monoclonal antibody is a passive immune preparation, which has the same or better neutralizing effect as rabies immunoglobulin. The development of anti-rabies virus monoclonal antibodies to replace traditional human immunoglobulin and immune antiserum products is an important direc…